Piramal Pharma Ltd (Mumbai) (PPLPHARMA) Stock Price & News

All values in INR	ዲሴም 2025	ማርች 2026	ጁን 2026	ሴፕቴ 2026
Revenue	21.40 ቢ	27.52 ቢ	22.70 ቢ	26.17 ቢ
Cost of goods sold	7.86 ቢ	13.95 ቢ	8.52 ቢ	9.06 ቢ
Cost of revenue	7.86 ቢ	13.95 ቢ	8.52 ቢ	9.06 ቢ
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	6.00 ቢ	8.19 ቢ	6.76 ቢ	7.14 ቢ
Operating expense	13.71 ቢ	11.09 ቢ	14.46 ቢ	15.95 ቢ
Total operating expenses	21.57 ቢ	25.04 ቢ	22.98 ቢ	25.01 ቢ
Operating income	-170.10 ሚ	2.47 ቢ	-283.50 ሚ	1.16 ቢ
Other non operating income	432.40 ሚ	-977.90 ሚ	894.10 ሚ	359.30 ሚ
EBT including unusual items	-938.60 ሚ	430.00 ሚ	-74.60 ሚ	816.30 ሚ
EBT excluding unusual items	-527.50 ሚ	1.40 ቢ	-74.60 ሚ	816.30 ሚ
Income tax expense	423.30 ሚ	518.30 ሚ	619.30 ሚ	766.00 ሚ
Effective tax rate	-45.10%	120.53%	-830.16%	93.84%
Other operating expenses	5.58 ቢ	723.30 ሚ	5.47 ቢ	6.48 ቢ
Net income	-1.36 ቢ	-88.30 ሚ	-693.90 ሚ	55.80 ሚ
Net profit margin	-6.36%	-0.32%	-3.06%	0.21%
Earnings per share	-0.72	1.32	-0.52	0.04
Interest and investment income	-	70.70 ሚ	-	-
Interest expense	-892.40 ሚ	-805.40 ሚ	-880.80 ሚ	-876.30 ሚ
Net interest expenses	-892.40 ሚ	-734.70 ሚ	-880.80 ሚ	-876.30 ሚ
Depreciation and amortization charges	2.13 ቢ	2.18 ቢ	2.24 ቢ	2.33 ቢ
EBITDA	1.68 ቢ	4.32 ቢ	1.57 ቢ	3.29 ቢ
Gain or loss from assets sale	-	-	-	-

Finance